Concepedia

David Walde

DW

Statistics

Publications

19

Citations

7.7K

H-Index

19

Active since

1971

Affiliations

Ontario Institute for Cancer Research(Current)

Essar Steel Algoma (Canada)

BC Cancer Agency

Hôtel-Dieu de Montréal

Ottawa Hospital

David Walde is an author at Ontario Institute for Cancer Research specializing in medicine, pharmacology, and oncology.

Publications per year

1971–2023

19

Publications

19

Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

Malcolm J. Moore, David Goldstein, John Hamm et al. · Journal of Clinical Oncology · 2007 · 3.9K citations

, , +17

Comparison of Oral Capecitabine Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Treatment in 605 Patients With Metastatic Colorectal Cancer: Results of a Randomized Phase III Study

Paulo M. Hoff, Rafat Ansari, Gerald Batist et al. · Journal of Clinical Oncology · 2001 · 1.1K citations

, , +14

Adjuvant Docetaxel for Node-Positive Breast Cancer

Miguel Martín, Tadeusz Pieńkowski, John R. Mackey et al. · New England Journal of Medicine · 2005 · 952 citations · Full text

, , +13

Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

Malcolm J. Moore, David Goldstein, John Hamm et al. · Journal of Clinical Oncology · 2023 · 277 citations

, , +17

Randomized, Double-Blind Trial of Carboplatin and Paclitaxel With Either Daily Oral Cediranib or Placebo in Advanced Non–Small-Cell Lung Cancer: NCIC Clinical Trials Group BR24 Study

Glenwood Goss, Andrew Arnold, Frances A. Shepherd et al. · Journal of Clinical Oncology · 2009 · 244 citations

, , +16

1–5 of 19